KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $42.9 million.

  • Charles River Laboratories International's Change in Accured Expenses rose 3755.93% to $42.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.2 million, marking a year-over-year increase of 41297.02%. This contributed to the annual value of -$27.6 million for FY2024, which is 32177.23% down from last year.
  • Per Charles River Laboratories International's latest filing, its Change in Accured Expenses stood at $42.9 million for Q3 2025, which was up 3755.93% from $23.7 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Change in Accured Expenses registered a high of $51.3 million during Q2 2021, and its lowest value of -$79.8 million during Q1 2022.
  • Its 5-year average for Change in Accured Expenses is $3.6 million, with a median of $5.4 million in 2022.
  • In the last 5 years, Charles River Laboratories International's Change in Accured Expenses soared by 56346.75% in 2023 and then plummeted by 18832.94% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Change in Accured Expenses (Quarter) stood at $26.1 million in 2021, then tumbled by 136.14% to -$9.4 million in 2022, then tumbled by 69.58% to -$16.0 million in 2023, then tumbled by 60.23% to -$25.6 million in 2024, then skyrocketed by 267.35% to $42.9 million in 2025.
  • Its last three reported values are $42.9 million in Q3 2025, $23.7 million for Q2 2025, and $15.3 million during Q1 2025.